These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30409872)

  • 1. A key ingredient for priming killer T cells.
    Barbet G; Blander JM
    Science; 2018 Nov; 362(6415):641-642. PubMed ID: 30409872
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural killer cells license dendritic cell cross-presentation of B lymphoma cell--associated antigens.
    Dao T; Gomez-Nunez M; Antczak C; Kappel B; Jaggi JS; Korontsvit T; Zakhaleva V; Scheinberg DA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8763-72. PubMed ID: 16361564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CD4 T cell help for CD8 CTL activation.
    Zhang S; Zhang H; Zhao J
    Biochem Biophys Res Commun; 2009 Jul; 384(4):405-8. PubMed ID: 19410556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Lymphocyte Subsets in the Immune Response to Primary B Cell-Derived Exosomes.
    Saunderson SC; McLellan AD
    J Immunol; 2017 Oct; 199(7):2225-2235. PubMed ID: 28842467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells.
    Iraolagoitia XL; Spallanzani RG; Torres NI; Araya RE; Ziblat A; Domaica CI; Sierra JM; Nuñez SY; Secchiari F; Gajewski TF; Zwirner NW; Fuertes MB
    J Immunol; 2016 Aug; 197(3):953-61. PubMed ID: 27342842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology. Licence to kill.
    Lanzavecchia A
    Nature; 1998 Jun; 393(6684):413-4. PubMed ID: 9623994
    [No Abstract]   [Full Text] [Related]  

  • 7. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of murine tumour growth through CD8
    Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
    Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen bias in T cell cross-priming.
    Wolkers MC; Brouwenstijn N; Bakker AH; Toebes M; Schumacher TN
    Science; 2004 May; 304(5675):1314-7. PubMed ID: 15166378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKG2D stimulation of CD8
    Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
    Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8+ T cells by dendritic cells loaded with killed allogeneic breast cancer cells.
    Saito H; Dubsky P; Dantin C; Finn OJ; Banchereau J; Palucka AK
    Breast Cancer Res; 2006; 8(6):R65. PubMed ID: 17129372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma.
    Nguyen-Pham TN; Im CM; Nguyen TA; Lim MS; Hong CY; Kim MH; Lee HJ; Lee YK; Cho D; Ahn JS; Yang DH; Kim YK; Chung IJ; Kim HJ; Lee JJ
    Leuk Res; 2011 Sep; 35(9):1241-7. PubMed ID: 21612823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo priming of natural killer T cells by dendritic cells pulsed with hepatoma-derived acid-eluted substances.
    Ishii R; Shimizu M; Nakagawa Y; Shimizu K; Tanaka S; Takahashi H
    Cancer Immunol Immunother; 2004 May; 53(5):383-90. PubMed ID: 14624311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal 0 for guided priming of CTLs: NKT cells do it too.
    Bousso P; Albert ML
    Nat Immunol; 2010 Apr; 11(4):284-6. PubMed ID: 20300136
    [No Abstract]   [Full Text] [Related]  

  • 16. Human anti-pig NK cell and CD8
    Madelon N; Puga Yung GL; Seebach JD
    Xenotransplantation; 2016 Nov; 23(6):479-489. PubMed ID: 27862343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
    Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
    J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rgamma(null) (NOG) mice.
    Inoue M; Senju S; Hirata S; Irie A; Baba H; Nishimura Y
    Immunol Lett; 2009 Sep; 126(1-2):67-72. PubMed ID: 19682495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destruction.
    Contassot E; Preynat-Seauve O; French L; Huard B
    Trends Immunol; 2009 Dec; 30(12):569-73. PubMed ID: 19837632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1.
    Hartung E; Becker M; Bachem A; Reeg N; Jäkel A; Hutloff A; Weber H; Weise C; Giesecke C; Henn V; Gurka S; Anastassiadis K; Mages HW; Kroczek RA
    J Immunol; 2015 Feb; 194(3):1069-79. PubMed ID: 25520399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.